Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
The market capitalization of the company stood at Rs. 7,000 crore +
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.
Subscribe To Our Newsletter & Stay Updated
